Serono and Nautilus Sign Hormone Agreement
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 55 (Table of Contents)
Published: 5 Jan-2005
DOI: 10.3833/pdr.v2005.i55.738 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Serono entered into an exclusive license agreement with Nautilus Biotech’s to develop human growth hormone and an option to license the exclusive worldwide rights to improved variants of the protein...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS